Showing results (1421-1430 of 9,902) with videos related to
Sort By:
Pageof 991
Bone Marrow Transplantation|March 5, 2008
Efficacy of glutamine-supplemented parenteral nutrition on short-term survival following allo-SCT: a randomized studyH O da Gama Torres, E G Vilela, A S da Cunha, et al.Bone Marrow Transplantation|April 1, 2008
Graft-versus-host disease following marrow transplantation for aplastic anemia: different impact of two GVHD prevention strategiesD Siegal, W Xu, R Sutherland, et al.Bone Marrow Transplantation|March 12, 2008
Early identification and management of graft failure after unrelated cord blood transplantationK W Chan, M S Grimley, C Taylor, et al.Bone Marrow Transplantation|March 12, 2008
Cell cycle and immune-related processes are significantly altered in chronic GVHDS J Oh, S B Cho, S-H Park, et al.Bone Marrow Transplantation|March 13, 2008
Allogeneic transplantation for ALL in adultsA Stein, S J FormanBone Marrow Transplantation|April 9, 2008
Allo-SCT using reduced-intensity conditioning against advanced pancreatic cancer: a Japanese surveyY Kanda, Y Omuro, E Baba, et al.Bone Marrow Transplantation|April 9, 2008
Impact of germinal center and non-germinal center phenotypes on overall and failure-free survival after high-dose chemotherapy and auto-SCT in primary diffuse large B-cell lymphomaH Nyman, E Jantunen, E Juvonen, et al.Bone Marrow Transplantation|April 9, 2008
Increasing mixed chimerism and the risk of graft loss in children undergoing allogeneic hematopoietic stem cell transplantation for non-malignant disordersE Ozyurek, M J Cowan, M A Koerper, et al.Bone Marrow Transplantation|November 18, 1998
Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cellsS Hohaus, H Martin, B Wassmann, et al.Bone Marrow Transplantation|November 18, 1998
High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancerL A Holmberg, T Demirer, S Rowley, et al.Pageof 991